Percentage of disabled RRMS subjects (EDSS score ≥3.5) with improvement in T25FW from best baseline walk over 30 months following randomization to natalizumab or placebo in the AFFIRM study: sensitivity analyses by consistency of improvement.
收藏Figshare2015-12-02 更新2026-04-29 收录
下载链接：
https://figshare.com/articles/dataset/_Percentage_of_disabled_RRMS_subjects_EDSS_score_8805_3_5_with_improvement_in_T25FW_from_best_baseline_walk_over_30_months_following_randomization_to_natalizumab_or_placebo_in_the_AFFIRM_study_sensitivity_analyses_by_consistency_of_improvement_/183647
下载链接
链接失效反馈官方服务：
资源简介：
P values assessing the difference between treatment groups based on two-sided Fisher exact test.RRMS, relapsing-remitting multiple sclerosis; EDSS, Expanded Disability Status Scale; T25FW, timed 25-foot walk.
创建时间：
2015-12-02
